Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Remternetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5815-1mg

IchorBio
1 mg Login
Compare
Remternetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5815-25mg

IchorBio
25 mg Login
Compare
Remternetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5815-50mg

IchorBio
50 mg Login
Compare
Remternetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5815-5mg

IchorBio
5 mg Login
Compare
Rinatabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5824-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Rinatabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5824-1mg

IchorBio
1 mg Login
Compare
Rinatabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5824-25mg

IchorBio
25 mg Login
Compare
Rinatabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5824-50mg

IchorBio
50 mg Login
Compare
Rinatabart Biosimilar -­ Research Grade Hu FA CHO cells ICH5824-5mg

IchorBio
5 mg Login
Compare
Rinucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5825-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Rinucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5825-1mg

IchorBio
1 mg Login
Compare
Rinucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5825-25mg

IchorBio
25 mg Login
Compare
Rinucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5825-50mg

IchorBio
50 mg Login
Compare
Rinucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5825-5mg

IchorBio
5 mg Login
Compare
Ripertamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5826-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Ripertamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5826-1mg

IchorBio
1 mg Login
Compare
Ripertamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5826-25mg

IchorBio
25 mg Login
Compare
Ripertamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5826-50mg

IchorBio
50 mg Login
Compare
Ripertamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5826-5mg

IchorBio
5 mg Login
Compare
Depatuxizumab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5294-1g

IchorBio
1 g Login
Compare
Depatuxizumab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5294-200mg

IchorBio
200 mg Login
Compare
Depatuxizumab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5294-500mg

IchorBio
500 mg Login
Compare
Loncastuximab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5298-1g

IchorBio
1 g Login
Compare
Loncastuximab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5298-200mg

IchorBio
200 mg Login
Compare
Loncastuximab Biosimilar -­ Research Grade Biosimilars Hu FA CHO cells ICH5298-500mg

IchorBio
500 mg Login
Compare
Name Price
Remternetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Remternetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Remternetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Remternetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Rinatabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Rinatabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Rinatabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Rinatabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Rinatabart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Rinucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Rinucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Rinucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Rinucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Rinucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Ripertamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Ripertamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Ripertamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Ripertamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Ripertamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Depatuxizumab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 g
Available
Depatuxizumab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 200 mg
Available
Depatuxizumab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 500 mg
Available
Loncastuximab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 g
Available
Loncastuximab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 200 mg
Available
Loncastuximab Biosimilar -­ Research Grade Login
Type Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 500 mg
Available

2719 Item(s)

per page